China unveils new five-year plan to boost biotech and pharma and compete globally

China's government released its latest five-year plan aimed at expanding the country's biotech and pharmaceutical sectors. The document outlines a strategy to strengthen research, development and manufacturing capabilities, positioning China as a major global competitor in biopharma.

The plan was announced on September 18, 2026, and is presented as a response to growing international demand for innovative medicines and vaccines. It emphasizes increased investment in cutting‑edge technologies and collaboration with overseas partners.

Officials say the initiative will accelerate the development of new drugs and improve the regulatory environment, helping Chinese firms bring products to market faster and expand their presence abroad.